Welcome to the Stocktwits Top 25 Newsletter this week!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date and tracks their performances over time. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

Here are the Stocktwits Top 25 Lists for this week:

AI hardware still owns the climb, but Friday’s list also exposed where momentum is cracking.

$MPWR ( ▼ 3.93% ) : Monolithic Power, Nasdaq 100 #23 to #13: Q3 revenue rose 63%, led by 165% enterprise-data growth from AI and server power systems. Risk: the climb depends heavily on that demand holding. Q3 filing

$AMAT ( ▼ 2.74% ) : Applied Materials, Nasdaq 100 #25 to #15: Record quarterly revenue jumped 53% to $10.41B, and management guided Q1 revenue to $11.1B. Risk: China supplied 25% of Q4 revenue, leaving export restrictions squarely in the setup. Q4 results

$MXL ( ▼ 5.39% ) : MaxLinear, Russell 2000 #22 to #14: Infrastructure revenue surged 210% as optical AI products ramped. Risk: management says anticipated growth is concentrated among a limited number of hyperscale customers and AI programs. Q3 results

$ETON ( ▲ 4.04% ) : Eton Pharmaceuticals, Russell 2000 #14 to #7: Q3 sales climbed 158% to $57.9M, prompting higher revenue and margin guidance. Risk: specialty pharmacy AnovoRx generated 94% of nine-month product revenue. Results 10-Q

$IBRX ( ▼ 0.82% ) : ImmunityBio, Russell 2000 #2 to #17: Momentum broke despite 53% ANKTIVA revenue growth and a broader FDA label. Risk: ImmunityBio carries a $480M related-party note and a $426M revenue-interest liability. Q3 results 10-Q

Next week’s swing factor: Nvidia reports Tuesday, November 17 at 5 pm ET. Its AI-spending outlook can reset the semiconductor names together. Nvidia schedule

Want to see some change? Respond to this email and reach me, Kevin Travers, with feedback. Follow me on Stocktwits. Send me charts and ideas! Refer a friend for this quarter’s edition of The RIP Forecast 😎

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋